IQV | tickerfilter.com

Fundamental analysis

48%

Profitability 31%

Dept financing 50%

Liquidity 13%

Performance 72%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-9.10%

1 Month

-3.26%

3 Months

-32.89%

6 Months

-27.14%

1 Year

6.64%

2 Year

-33.28%

Key data

Stock price

$160.68

P/E Ratio

28.23

DAY RANGE

$156.32 - $168.64

EPS

$7.91

52 WEEK RANGE

$134.64 - $247.04

52 WEEK CHANGE

$6.92

MARKET CAP

38.387 B

YIELD

N/A

SHARES OUTSTANDING

169.700 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.63

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,500,687

AVERAGE 30 VOLUME

$1,397,691

Company detail

CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013

Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

IQV - IQVIA HOLDINGS INC.